nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmethylphenidate—Vasculitis necrotising—Hydrochlorothiazide—nephrolithiasis	0.0613	0.0718	CcSEcCtD
Dexmethylphenidate—Cardiac murmur—Hydrochlorothiazide—nephrolithiasis	0.0415	0.0486	CcSEcCtD
Dexmethylphenidate—Anorectal disorder—Hydrochlorothiazide—nephrolithiasis	0.0244	0.0286	CcSEcCtD
Dexmethylphenidate—Toothache—Hydrochlorothiazide—nephrolithiasis	0.0211	0.0247	CcSEcCtD
Dexmethylphenidate—Feeling hot—Hydrochlorothiazide—nephrolithiasis	0.0164	0.0192	CcSEcCtD
Dexmethylphenidate—Cyclopentolate—CHRM3—nephrolithiasis	0.0158	0.236	CrCbGaD
Dexmethylphenidate—Hyoscyamine—CHRM3—nephrolithiasis	0.0141	0.21	CrCbGaD
Dexmethylphenidate—Homatropine Methylbromide—CHRM3—nephrolithiasis	0.0133	0.198	CrCbGaD
Dexmethylphenidate—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.0132	0.0154	CcSEcCtD
Dexmethylphenidate—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.0121	0.0141	CcSEcCtD
Dexmethylphenidate—Atropine—CHRM3—nephrolithiasis	0.012	0.179	CrCbGaD
Dexmethylphenidate—Ipratropium bromide—CHRM3—nephrolithiasis	0.0119	0.177	CrCbGaD
Dexmethylphenidate—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0136	CcSEcCtD
Dexmethylphenidate—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.0108	0.0126	CcSEcCtD
Dexmethylphenidate—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0126	CcSEcCtD
Dexmethylphenidate—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0124	CcSEcCtD
Dexmethylphenidate—Swelling—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0124	CcSEcCtD
Dexmethylphenidate—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0123	CcSEcCtD
Dexmethylphenidate—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.0102	0.012	CcSEcCtD
Dexmethylphenidate—Injury—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0119	CcSEcCtD
Dexmethylphenidate—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0118	CcSEcCtD
Dexmethylphenidate—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.00997	0.0117	CcSEcCtD
Dexmethylphenidate—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.00993	0.0116	CcSEcCtD
Dexmethylphenidate—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.00989	0.0116	CcSEcCtD
Dexmethylphenidate—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.00989	0.0116	CcSEcCtD
Dexmethylphenidate—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.00985	0.0115	CcSEcCtD
Dexmethylphenidate—Thirst—Hydrochlorothiazide—nephrolithiasis	0.0098	0.0115	CcSEcCtD
Dexmethylphenidate—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00933	0.0109	CcSEcCtD
Dexmethylphenidate—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.00926	0.0108	CcSEcCtD
Dexmethylphenidate—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00918	0.0108	CcSEcCtD
Dexmethylphenidate—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00918	0.0108	CcSEcCtD
Dexmethylphenidate—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00884	0.0104	CcSEcCtD
Dexmethylphenidate—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.00861	0.0101	CcSEcCtD
Dexmethylphenidate—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.00852	0.00998	CcSEcCtD
Dexmethylphenidate—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00843	0.00987	CcSEcCtD
Dexmethylphenidate—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.0084	0.00984	CcSEcCtD
Dexmethylphenidate—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00826	0.00967	CcSEcCtD
Dexmethylphenidate—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00823	0.00964	CcSEcCtD
Dexmethylphenidate—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00806	0.00944	CcSEcCtD
Dexmethylphenidate—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00791	0.00926	CcSEcCtD
Dexmethylphenidate—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00785	0.0092	CcSEcCtD
Dexmethylphenidate—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00749	0.00878	CcSEcCtD
Dexmethylphenidate—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00743	0.0087	CcSEcCtD
Dexmethylphenidate—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00736	0.00862	CcSEcCtD
Dexmethylphenidate—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00734	0.00859	CcSEcCtD
Dexmethylphenidate—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00723	0.00847	CcSEcCtD
Dexmethylphenidate—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00713	0.00835	CcSEcCtD
Dexmethylphenidate—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00709	0.0083	CcSEcCtD
Dexmethylphenidate—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00705	0.00825	CcSEcCtD
Dexmethylphenidate—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00699	0.00819	CcSEcCtD
Dexmethylphenidate—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00689	0.00807	CcSEcCtD
Dexmethylphenidate—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00686	0.00803	CcSEcCtD
Dexmethylphenidate—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00678	0.00794	CcSEcCtD
Dexmethylphenidate—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00675	0.0079	CcSEcCtD
Dexmethylphenidate—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00657	0.0077	CcSEcCtD
Dexmethylphenidate—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00647	0.00758	CcSEcCtD
Dexmethylphenidate—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00641	0.0075	CcSEcCtD
Dexmethylphenidate—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00622	0.00728	CcSEcCtD
Dexmethylphenidate—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.0061	0.00715	CcSEcCtD
Dexmethylphenidate—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00599	0.00702	CcSEcCtD
Dexmethylphenidate—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00577	0.00675	CcSEcCtD
Dexmethylphenidate—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.0057	0.00668	CcSEcCtD
Dexmethylphenidate—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00562	0.00658	CcSEcCtD
Dexmethylphenidate—Tension—Hydrochlorothiazide—nephrolithiasis	0.00551	0.00646	CcSEcCtD
Dexmethylphenidate—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00546	0.00639	CcSEcCtD
Dexmethylphenidate—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00543	0.00637	CcSEcCtD
Dexmethylphenidate—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.0054	0.00633	CcSEcCtD
Dexmethylphenidate—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.0053	0.0062	CcSEcCtD
Dexmethylphenidate—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00526	0.00617	CcSEcCtD
Dexmethylphenidate—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00521	0.00611	CcSEcCtD
Dexmethylphenidate—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00519	0.00608	CcSEcCtD
Dexmethylphenidate—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00516	0.00605	CcSEcCtD
Dexmethylphenidate—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00513	0.00601	CcSEcCtD
Dexmethylphenidate—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00507	0.00593	CcSEcCtD
Dexmethylphenidate—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00505	0.00591	CcSEcCtD
Dexmethylphenidate—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00504	0.0059	CcSEcCtD
Dexmethylphenidate—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00503	0.00589	CcSEcCtD
Dexmethylphenidate—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00497	0.00582	CcSEcCtD
Dexmethylphenidate—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00494	0.00578	CcSEcCtD
Dexmethylphenidate—Cough—Hydrochlorothiazide—nephrolithiasis	0.0049	0.00574	CcSEcCtD
Dexmethylphenidate—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00478	0.0056	CcSEcCtD
Dexmethylphenidate—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00478	0.0056	CcSEcCtD
Dexmethylphenidate—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00478	0.0056	CcSEcCtD
Dexmethylphenidate—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00477	0.00558	CcSEcCtD
Dexmethylphenidate—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00473	0.00554	CcSEcCtD
Dexmethylphenidate—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00468	0.00548	CcSEcCtD
Dexmethylphenidate—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00462	0.00542	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00459	0.00537	CcSEcCtD
Dexmethylphenidate—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00459	0.00537	CcSEcCtD
Dexmethylphenidate—Shock—Hydrochlorothiazide—nephrolithiasis	0.00451	0.00528	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00449	0.00526	CcSEcCtD
Dexmethylphenidate—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00448	0.00524	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00443	0.00519	CcSEcCtD
Dexmethylphenidate—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00437	0.00512	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00418	0.00489	CcSEcCtD
Dexmethylphenidate—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00415	0.00486	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00412	0.00482	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00409	0.00479	CcSEcCtD
Dexmethylphenidate—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00408	0.00477	CcSEcCtD
Dexmethylphenidate—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00404	0.0511	CbGpPWpGaD
Dexmethylphenidate—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00404	0.00473	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00399	0.00467	CcSEcCtD
Dexmethylphenidate—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00395	0.00463	CcSEcCtD
Dexmethylphenidate—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00392	0.00459	CcSEcCtD
Dexmethylphenidate—Pain—Hydrochlorothiazide—nephrolithiasis	0.00392	0.00459	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00378	0.00443	CcSEcCtD
Dexmethylphenidate—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00376	0.0475	CbGpPWpGaD
Dexmethylphenidate—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00375	0.00439	CcSEcCtD
Dexmethylphenidate—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00364	0.00427	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00362	0.00425	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00362	0.00425	CcSEcCtD
Dexmethylphenidate—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00358	0.0453	CbGpPWpGaD
Dexmethylphenidate—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00338	0.00396	CcSEcCtD
Dexmethylphenidate—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00333	0.0421	CbGpPWpGaD
Dexmethylphenidate—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00329	0.00385	CcSEcCtD
Dexmethylphenidate—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00324	0.0038	CcSEcCtD
Dexmethylphenidate—SLC6A4—NRF2 pathway—SLC2A9—nephrolithiasis	0.00315	0.0398	CbGpPWpGaD
Dexmethylphenidate—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00314	0.00367	CcSEcCtD
Dexmethylphenidate—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00303	0.00355	CcSEcCtD
Dexmethylphenidate—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00292	0.00341	CcSEcCtD
Dexmethylphenidate—Rash—Hydrochlorothiazide—nephrolithiasis	0.00289	0.00339	CcSEcCtD
Dexmethylphenidate—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00289	0.00338	CcSEcCtD
Dexmethylphenidate—Headache—Hydrochlorothiazide—nephrolithiasis	0.00287	0.00336	CcSEcCtD
Dexmethylphenidate—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00272	0.00319	CcSEcCtD
Dexmethylphenidate—SLC6A2—NRF2 pathway—SLC2A9—nephrolithiasis	0.00271	0.0343	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00265	0.0335	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00243	0.0306	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00243	0.0306	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—NRF2 pathway—SLC2A9—nephrolithiasis	0.0024	0.0304	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00235	0.0297	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00215	0.0272	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00215	0.0272	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00184	0.0232	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00184	0.0232	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00171	0.0216	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00171	0.0216	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00163	0.0206	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00163	0.0206	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00152	0.0192	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00151	0.0191	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00151	0.0191	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00151	0.0191	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00151	0.0191	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00135	0.017	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00135	0.017	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00134	0.0169	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00134	0.0169	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00123	0.0156	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00123	0.0156	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00119	0.0151	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00109	0.0138	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00109	0.0138	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.000987	0.0125	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000934	0.0118	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000934	0.0118	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000868	0.011	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000868	0.011	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000827	0.0105	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000827	0.0105	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000774	0.00978	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000774	0.00978	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000769	0.00972	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000769	0.00972	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000686	0.00866	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000686	0.00866	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000619	0.00782	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000548	0.00693	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.000223	0.00281	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.000198	0.00251	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.000169	0.00213	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—APRT—nephrolithiasis	0.000169	0.00213	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—AQP1—nephrolithiasis	0.00012	0.00152	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CHRM3—nephrolithiasis	0.000109	0.00137	CbGpPWpGaD
